Please use this identifier to cite or link to this item:
http://elar.urfu.ru/handle/10995/90538
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gusev, E. Yu. | en |
dc.contributor.author | Zotova, N. V. | en |
dc.contributor.author | Zhuravleva, Yu. A. | en |
dc.contributor.author | Chereshnev, V. A. | en |
dc.date.accessioned | 2020-09-29T09:47:46Z | - |
dc.date.available | 2020-09-29T09:47:46Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Physiological and pathogenic role of scavenger receptors in humans / E. Yu. Gusev, N. V. Zotova, Yu. A. Zhuravleva, V. A. Chereshnev. — DOI 10.15789/1563-0625-PAP-1893 // Medical Immunology (Russia). — 2020. — Vol. 1. — Iss. 22. — P. 7-48. | en |
dc.identifier.issn | 1563-0625 | - |
dc.identifier.other | https://www.mimmun.ru/mimmun/article/download/1893/1222 | |
dc.identifier.other | 1 | good_DOI |
dc.identifier.other | 1aee3b66-10dc-4f37-af96-cb0df3d13e7d | pure_uuid |
dc.identifier.other | http://www.scopus.com/inward/record.url?partnerID=8YFLogxK&scp=85082651678 | m |
dc.identifier.uri | http://elar.urfu.ru/handle/10995/90538 | - |
dc.description.abstract | The scavenger receptors (SRs)) include > 30 different molecules structurally classified into 11 classes (A to L). They are expressed mostly on stromal macrophages, and their expression may be augmented in direct dependence with concentrations of their ligands. The SRs are heterogenous by their structure, however, being common in their functional potential. E.g., different SR classes may participate in absorption of modified low-density lipoproteins and glycated proteins, apoptotic and ageing cells, altered erythrocytes and platelets, like as a big variety of other endogenous ligands from metabolic and cellular “trash”. A common property of SRs is their participation in removal of small pathogen amounts from blood circulation, regulation of cell and tissue stress responses, ability to form complicated receptor complexes with other receptor types including integrins and toll-like receptors. Opposite to classic pattern-recognizing receptors, the SR involvement does not always elicit a pronounced cellular activation and development of pro-inflammatory cellular stress. The SR functional effects provide interactions between different physiological events and immune system, including the processes of neuroendocrine and metabolic regulation. These mechanisms provide both homeostatic stability and, likewise, act at the border of normal and pathological conditions, i.e., participating in pathogenesis of transitional processes, e.g., physiological ageing. Moreover, the SR-associated processes represent a key pathogenetic factor in different somatic diseases, e.g., those associated with low-intensity chronic inflammation, including obesity, type 2 diabetes, atherosclerosis, arterial hypertension, various neurodegenerative disorders. Similarly, the SRs are involved into the processes of cancer transformation and antitumor response, different processes of classical inflammation, from antigen presentation to the morphofunctional T cell and macrophage polarization in the inflammation foci and immunocompetent organs. SR are playing a controversial role in development of acute systemic inflammation, the main reason for lethal outcomes in the intensive care wards. Targeted effects upon the SRs represent a promising approach when treating a broad variety of diseases, whereas detection of membrane-bound and soluble SR forms could be performed by means of diagnostic and monitoring techniques in many human disorders. © 2020, SPb RAACI. | en |
dc.format.mimetype | application/pdf | en |
dc.language.iso | ru | en |
dc.publisher | Russian Association of Allergologists and Clinical Immunologists, St. Petersburg Regional Branch (SPb RAACI) | en |
dc.rights | info:eu-repo/semantics/openAccess | en |
dc.rights | cc-by | other |
dc.source | Medical Immunology (Russia) | en |
dc.subject | ATHEROSCLEROSIS | en |
dc.subject | LOW-GRADE CHRONIC INFLAMMATION | en |
dc.subject | NEURODEGENERATION | en |
dc.subject | POLARIZATION OF MACROPHAGES | en |
dc.subject | SCAVENGER RECEPTORS | en |
dc.subject | SYSTEMIC INFLAMMATION | en |
dc.subject | TISSUE STRESS | en |
dc.subject | TUMOR DISEASES | en |
dc.subject | OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1 | en |
dc.subject | PATTERN RECOGNITION RECEPTOR | en |
dc.subject | SCAVENGER RECEPTOR | en |
dc.subject | SCAVENGER RECEPTOR A | en |
dc.subject | SCAVENGER RECEPTOR B | en |
dc.subject | SCAVENGER RECEPTOR C | en |
dc.subject | SCAVENGER RECEPTOR D | en |
dc.subject | SCAVENGER RECEPTOR F | en |
dc.subject | SCAVENGER RECEPTOR G | en |
dc.subject | SCAVENGER RECEPTOR H | en |
dc.subject | SCAVENGER RECEPTOR I | en |
dc.subject | SCAVENGER RECEPTOR J | en |
dc.subject | SCAVENGER RECEPTOR K | en |
dc.subject | SCAVENGER RECEPTOR L | en |
dc.subject | UNCLASSIFIED DRUG | en |
dc.subject | ANTIGEN PRESENTATION | en |
dc.subject | ARTICLE | en |
dc.subject | ATHEROSCLEROSIS | en |
dc.subject | CELL AGING | en |
dc.subject | CELL STRESS | en |
dc.subject | CHRONIC INFLAMMATION | en |
dc.subject | CIRCULATION | en |
dc.subject | DEGENERATIVE DISEASE | en |
dc.subject | HOMEOSTASIS | en |
dc.subject | HUMAN | en |
dc.subject | HYPERTENSION | en |
dc.subject | IMMUNOCOMPETENCE | en |
dc.subject | INFLAMMATION | en |
dc.subject | MACROPHAGE | en |
dc.subject | NON INSULIN DEPENDENT DIABETES MELLITUS | en |
dc.subject | OBESITY | en |
dc.subject | PATHOGENESIS | en |
dc.subject | PHYSIOLOGICAL PROCESS | en |
dc.subject | PROTEIN EXPRESSION | en |
dc.subject | PROTEIN FUNCTION | en |
dc.subject | PROTEIN INTERACTION | en |
dc.subject | REGULATORY MECHANISM | en |
dc.subject | T LYMPHOCYTE | en |
dc.title | Physiological and pathogenic role of scavenger receptors in humans | en |
dc.type | Article | en |
dc.type | info:eu-repo/semantics/article | en |
dc.type | info:eu-repo/semantics/publishedVersion | en |
dc.identifier.rsi | 42195020 | - |
dc.identifier.doi | 10.15789/1563-0625-PAP-1893 | - |
dc.identifier.scopus | 85082651678 | - |
local.affiliation | Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences, Ekaterinburg, Russian Federation | en |
local.affiliation | B. Eltsin Ural Federal University, Ekaterinburg, Russian Federation | en |
local.contributor.employee | Gusev, E.Yu., Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences, Ekaterinburg, Russian Federation | ru |
local.contributor.employee | Zotova, N.V., Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences, Ekaterinburg, Russian Federation, B. Eltsin Ural Federal University, Ekaterinburg, Russian Federation | ru |
local.contributor.employee | Zhuravleva, Yu.A., Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences, Ekaterinburg, Russian Federation | ru |
local.contributor.employee | Chereshnev, V.A., Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences, Ekaterinburg, Russian Federation | ru |
local.description.firstpage | 7 | - |
local.description.lastpage | 48 | - |
local.issue | 22 | - |
local.volume | 1 | - |
local.identifier.pure | 12264960 | - |
local.identifier.eid | 2-s2.0-85082651678 | - |
Appears in Collections: | Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
10.15789-1563-0625-PAP-1893.pdf | 786,81 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.